Uncategorized
Amniotic Fluid Stem Cells (AFSC): The Youngest & High-Potential Stem Cells Globally
Holder of exclusive global patents for isolation and purification. As the youngest stem cells, Amniotic Fluid Stem Cells (AFSCs) possess safety, high differentiation, and other key characteristics. This scientific discovery was selected by TIME Magazine as one of the Top 10 Medical Breakthroughs. U-NEURON continues to advance its R&D and clinical applications.
Investigational Drug UA002: World’s First AFSC-Based Drug Candidate to Enter Phase II Clinical Trials
The world's first AFSC-based investigational drug to enter Phase II clinical trials. UA002 focuses on treating erectile dysfunction associated with surgery and diabetes, and is currently undergoing clinical trials in parallel at three major medical centers: Taipei Medical University Hospital, Fu Jen Catholic University Hospital, and Taichung Veterans General Hospital.